Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

8.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

755
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
755
Hematopoiesis01:21

Hematopoiesis

8.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stemness as the Engine of Checkpoint Durability.

The New England journal of medicine·2026
Same author

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

Nature medicine·2026
Same author

Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease.

The New England journal of medicine·2026
Same author

NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advanced deep learning enables prediction of allogeneic stem cell mobilization success.

Bone marrow transplantation·2026
Same author

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.

Nature communications·2026

Related Experiment Video

Updated: Dec 29, 2025

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.4K

Mobilized peripheral blood: an updated perspective.

Darja Karpova1, Michael P Rettig2, John F DiPersio2

  • 1Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, 69120, Germany.

F1000Research
|February 7, 2020
PubMed
Summary

Hematopoietic stem cell (HSC) mobilization research advances optimize current strategies for better pharmacokinetic profiles, cost-effectiveness, and donor convenience. Future developments will impact HSC collection, chemosensitization, conditioning, and gene therapy applications.

Keywords:
BM nicheCXCR2CXCR4ChemosensitizationConditioningG-CSFGene therapyHematopoietic stem and progenitor cellsMobilizationVLA4

More Related Videos

Author Spotlight: Advancements in PBMC Isolation &#8211; Enhancing Throughput and Consistency in Research
06:23

Author Spotlight: Advancements in PBMC Isolation – Enhancing Throughput and Consistency in Research

Published on: July 19, 2024

5.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.1K

Related Experiment Videos

Last Updated: Dec 29, 2025

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.4K
Author Spotlight: Advancements in PBMC Isolation &#8211; Enhancing Throughput and Consistency in Research
06:23

Author Spotlight: Advancements in PBMC Isolation – Enhancing Throughput and Consistency in Research

Published on: July 19, 2024

5.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.1K

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Pharmacology

Background:

  • Hematopoietic stem cell (HSC) mobilization, the enforced egress from bone marrow (BM) to peripheral circulation, has been studied for over 40 years.
  • Current mobilization research aims to refine clinical regimens for improved pharmacokinetic/pharmacodynamic profiles, reduced costs, and enhanced donor convenience.

Purpose of the Study:

  • To review recent findings in HSC mobilization research.
  • To discuss the anticipated impact of these findings on future mobilization strategies.
  • To explore the significance of mobilization beyond HSC collection, including applications in chemosensitization, conditioning, and gene therapy, and its role in studying HSC-BM microenvironment interactions.

Main Methods:

  • Literature review of recent advancements in hematopoietic stem cell mobilization.
  • Analysis of current trends and future directions in mobilization research.
  • Discussion of open questions, controversies, and the impact of technological progress.

Main Results:

  • Recent findings are refining mobilization strategies for clinical application.
  • Mobilization holds significance beyond HSC collection, impacting cancer therapy and gene therapy.
  • Understanding HSC-BM microenvironment interactions is a key area of research.

Conclusions:

  • Continued research is crucial for optimizing HSC mobilization protocols.
  • Mobilization strategies are evolving with potential for broader therapeutic applications.
  • Addressing current controversies and leveraging technological advancements will drive future progress.